Immunosuppression, hepatitis C infection, and acute renal failure in HIV-infected patients

被引:23
作者
Franceschini, Nora
Napravnik, Sonia
Finn, William F.
Szczech, Lynda A.
Eron, Joseph J., Jr.
机构
[1] Univ N Carolina, Dept Epidemiol, Sch Publ Hlth, Chapel Hill, NC 27514 USA
[2] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA
[3] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC USA
[4] Univ N Carolina, Sch Med, Div Nephrol & Hypertens, Chapel Hill, NC USA
[5] Duke Univ, Div Nephrol, Durham, NC USA
关键词
HIV; epidemiology; incidence; risk factors; acute renal failure; hepatitis C;
D O I
10.1097/01.qai.0000220165.79736.d3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Low CD4 cell Counts predict HIV-related morbidity and mortality and may be associated with acute renal failure (ARF). Objective: To estimate the effect of CD4 cell count on the incidence rate (IR) of ARF in ambulatory HIV-infected patients with access to highly active antiretroviral therapy. Methods: Observational clinical cohort of HIV-infected patients recruited from a university-based infectious diseases clinic, between 2000 and 2002, and followed up until December 31, 2002. Poisson log-linear regression models were used to calculate ARF IRs, IR differences, and IR ratios. Results: The mean age of the 705 study participants was 40 years, two thirds were male, and 61% were African American. Incidence rates of ARF were higher at lower CD4 cell counts and among patients who were coinfected with hepatitis C. Patients with hepatitis C coinfection who also had low CD4 cell counts had the highest adjusted IR of ARF. Conclusion: Immunosuppression and hepatitis C virus coinfection are associated with increased IRs of ARF in ambulatory HIV-1-infected patients.
引用
收藏
页码:368 / 372
页数:5
相关论文
共 22 条
  • [11] Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome:: A retrospective multicenter study
    Moreau, R
    Durand, F
    Poynard, T
    Duhamel, C
    Cervoni, JP
    Ichaï, P
    Abergel, A
    Halimi, C
    Pauwels, M
    Bronowicki, JP
    Giostra, E
    Fleurot, C
    Gurnot, D
    Nouel, O
    Renard, P
    Rivoal, M
    Blanc, P
    Coumaros, D
    Ducloux, S
    Levy, S
    Pariente, A
    Perarnau, JM
    Roche, J
    Scribe-Outtas, M
    Valla, D
    Bernard, B
    Samuel, D
    Butel, J
    Hadengue, A
    Platek, A
    Lebrec, D
    Cadranel, JF
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : 923 - 930
  • [12] HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia
    Napravnik, S
    Edwards, D
    Stewart, P
    Stalzer, B
    Matteson, E
    Eron, JJ
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (01) : 34 - 40
  • [13] Hospital-acquired renal insufficiency
    Nash, K
    Hafeez, A
    Hou, S
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (05) : 930 - 936
  • [14] Olsen CH, 2005, AIDS, V19, P319
  • [15] RAO TKS, 1995, AM J KIDNEY DIS, V25, P390
  • [16] THE TYPES OF RENAL-DISEASE IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    RAO, TKS
    FRIEDMAN, EA
    NICASTRI, AD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (17) : 1062 - 1068
  • [17] Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy
    Rockstroh, JK
    Mocroft, A
    Soriano, V
    Tural, C
    Losso, MH
    Horban, A
    Kirk, O
    Phillips, A
    Ledergerber, B
    Lundgren, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (06) : 992 - 1002
  • [18] Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death:: a prospective cohort study
    Sterne, JAC
    Hernán, MA
    Ledergerber, B
    Tilling, K
    Weber, R
    Sendi, P
    Rickenbach, M
    Robins, JM
    Egger, M
    [J]. LANCET, 2005, 366 (9483) : 378 - 384
  • [19] Hepatitis C and progression of HIV disease
    Sulkowski, MS
    Moore, RD
    Mehta, SH
    Chaisson, RE
    Thomas, DL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (02): : 199 - 206
  • [20] *US PUBL HLTH SERV, 2005, GUID USE ANT AG HIV